Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present NeuroMetrix, Inc. (NASDAQ: NURO).

Full DD Report for NURO

You must become a subscriber to view this report.


Recent News from (NASDAQ: NURO)

Free Technical Snapshots for Ekso Bionics and Three More Medical Supplies Stocks
Stock Research Monitor: HAE, HRC, and NURO LONDON, UK / ACCESSWIRE / May 11, 2018/ If you want a free Stock Review on EKSO sign up now at www.wallstequities.com/registration . WallStEquities.com has initiated research coverage on Ekso Bionics Holdings Inc. (NASDAQ: EKSO ), Haemonet...
Source: ACCESSWIRE IA
Date: May, 11 2018 07:10
Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress
WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that preliminary results from a study of Quell ® wearable pain relief in chronic low back pain will be presented at the 9th World Congress of the World Institute of Pain in Dublin, Ireland...
Source: GlobeNewswire
Date: May, 03 2018 11:00
NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City
WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it will be participating in the 3rd annual Disruptive Growth & Healthcare Conference in New York City on May 8-9, 2018 sponsored by RHK Capital and ReedSmith. The conference offers an ...
Source: GlobeNewswire
Date: May, 01 2018 11:00
NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting
WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will present two scientific posters at the upcoming 2018 American Academy of Pain Medicine (AAPM) Annual Meeting to be held in Vancouver, Canada, April 26-28. The two posters are tit...
Source: GlobeNewswire
Date: April, 24 2018 11:00
NeuroMetrix's (NURO) CEO Shai Gozani on Q1 2018 Results - Earnings Call Transcript
NeuroMetrix, Inc. (NURO) Q1 2018 Results Earnings Conference Call April 19, 2018, 08:00 AM ET Executives Thomas Higgins - Senior Vice President and Chief Financial Officer Shai Gozani - President and Chief Executive Officer Analysts Jared Cohen - JM Cowen & Company Mani...
Source: SeekingAlpha
Date: April, 19 2018 10:46
Premarket Gainers as of 9:05 am (04/19/2018)
BPTH +20%  after presentation  of prexigebersen data. More news on: Bio-Path Holdings, Inc., Sientra, W.W. Grainger, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 19 2018 09:09
NeuroMetrix Reports Q1 2018 Financial Results
WALTHAM, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended March 31, 2018. The Company develops and markets novel therapies, based on neurostimulation and digital medicine, for chronic health ...
Source: GlobeNewswire
Date: April, 19 2018 07:00
NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting
WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will present a scientific poster at the upcoming 2018 American Academy of Neurology (AAN) Annual Meeting to be held in Los Angeles, CA, April 21-27. The poster is titled: “Pil...
Source: GlobeNewswire
Date: April, 18 2018 13:59
NeuroMetrix, Inc. Announces Date for 2018 First Quarter Financial Results Conference Call
WALTHAM, Mass., April 11, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2018 first quarter financial results before the opening of the market on Thursday, April 19, 2018. The Company will host a conference call at 8:00 a.m...
Source: GlobeNewswire
Date: April, 11 2018 11:00
NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief
WALTHAM, Mass., April 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of results from a clinical study of Quell® in the Journal of Pain Research.  The paper is titled “Effectiveness of fixed-site high-frequency transcutaneous electri...
Source: GlobeNewswire
Date: April, 10 2018 14:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-171.251.241.261.211421,926
2018-08-161.231.2111.241.200133,326
2018-08-151.191.221.241.1921,776
2018-08-141.261.201.261.1934,318
2018-08-131.201.241.271.19179,930

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-172,4007,75830.9358Cover
2018-08-1670416,5444.2553Cover
2018-08-151,6189,77116.5592Cover
2018-08-1411,31530,70236.8543Short
2018-08-1338,50976,78750.1504Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NURO.


About NeuroMetrix, Inc. (NASDAQ: NURO)

Logo for NeuroMetrix, Inc. (NASDAQ: NURO)

Not available

 

Contact Information

 

 

Current Management

  • Shai N. Gozani / President, CEO
  • Thomas T. Higgi / CFO

Current Share Structure

  • Market Cap: $10,670,058 - 03/21/2018
  • Issue and Outstanding: 7,141,940 - 02/02/2018

 


Recent Filings from (NASDAQ: NURO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 20 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 19 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: March, 23 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: March, 23 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 09 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 09 2018

 

 


Daily Technical Chart for (NASDAQ: NURO)

Daily Technical Chart for (NASDAQ: NURO)


Stay tuned for daily updates and more on (NASDAQ: NURO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NURO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NURO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of NURO and does not buy, sell, or trade any shares of NURO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/